Technivie (ombitasvir, paritaprevir, and ritonavir)
What types of adverse reactions were reported when taking Technivie?
UPDATE: AbbVie discontinued Technivie effective December 31, 2018.
In clinical studies of Technivie and ribavirin, the most commonly reported side effects (> 10% of subjects) were asthenia (weakness), fatigue, nausea and insomnia.
Last Updated: December 2018
Bristol-Myers wins approval for 1st hepatitis C type 3 drug. http://www.washingtontimes.com/news/2015/jul/24/bristol-myers-wins-approval-for-1st-hepatitis-c-ty/, The Washington Times. Retrieved July 28, 2015.
Highlights of Prescribing Information - TECHNIVIE. http://rxabbvie.com/pdf/technivie_pi.pdf, AbbVie, Inc. Retrieved July 28, 2015.